Several studies have examined the effect of GLI inhibition in GBM cells in vitro and found that treatment with GLI inhibitors, like GANT61, results in decreased expression of MGMT and re-sensitization to TMZ (148, 150, 151). This evidence concerns the gene GLI1 and glioblastoma.